Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer (Q35730375)
Jump to navigation
Jump to search
scientific article published on July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer |
scientific article published on July 2008 |
Statements
1 reference
Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer (English)
1 reference
Christine B Ambrosone
1 reference
Thomas C Krivak
1 reference
Kathleen M Darcy
1 reference
Chunqiao Tian
1 reference
Deborah Armstrong
1 reference
Bora E Baysal
1 reference
Holly Gallion
1 reference
Julie A DeLoia
1 reference
Gynecologic Oncology Group Phase III Trial
1 reference
1 July 2008
1 reference
1 reference
26
1 reference
21
1 reference
3598-3606
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference